Port Grimaud Realestate
HomeMoneyBriefing: DAFNA Capital Trims iShares Biotechnology ETF With…
Money

Briefing: DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing

Strategic angle: DAFNA Capital has made adjustments to its holdings in the iShares Biotechnology ETF as part of a broader strategy in the biotech sector.

Editorial StaffMarch 21, 20261 min read

DAFNA Capital's recent SEC filing reveals changes in ETF holdings.

The adjustments reflect a strategic shift in their biotech portfolio.

iShares Biotechnology ETF remains a key component of their investments.